Erowid Ibogaine Vault : Timeline

Ibogaine

Timeline

by Erowid

1864		First report of the use of Tabernanthe iboga root as a stimulant and aphrodisiac in Gabon and the Congo, made by Griffon du Bellay, a doctor in the French navy, who took specimens to France. 1
1889		The genus Tabernanthe is established and the botanical description of T. iboga is made by Henri Baillon at the Museum National d'Histoire Naturelle in Paris. 2
late 19th Century		The Fang of Gabon founded a syncretic Christian church called "Bwiti" which uses T. iboga in its initiation rites. The Fang believe that T. iboga use was originally discovered by the Pygmies. [Details] The initiate is believed to make direct contact with their ancestors, forming a stronger link to their past.
1901		Ibogaine first isolated from Tabernanthe iboga by Dybowsky and Landrin. 2
1903		First report of the cultural use of Tabernanthe iboga as a visionary plant in the Congo. 1
1939		An extract of Tabernanthe manii was sold in tablet form under the name Lambarene (the name of a city in Gabon), for the treatment of fatigue and depression. It contained .2 g extract per tablet, approximately 8 mg of ibogaine. It was popular among athletes who used it as a stimulant and to accelerate red blood cell production. Lambarene disappeared from the market around 1966. 2
1962-1963		Howard Lotsof conducts experiments into Ibogaine's use in the treatment of cocaine and heroin addiction. 3
1966		The complete synthesis of ibogaine is accomplished. 4
Nov 22, 1967		Bufotenine, DET, and Ibogaine were placed under DACA control in the United States, making them illegal to possess, sell, or manufacture except for personal use. 5
Oct 24, 1968		Possession of Ibogaine is banned federally in the U.S. after the passage of the Staggers-Dodd Bill (Public Law 90-639) which amended the Food, Drug, and Cosmetic Act.
1972		Ibogaine detected in some samples of street drugs in the U.S. 6 [Details] Two samples of brown organic-looking powder, "sold on the street as unknown drugs", are submitted to a U.S. street drug analysis program and found to contain ibogaine.
1985		Ibogaine patented for use in treating Heroin addiction. 7
1954-1958		The structure of the ibogaine molecule is determined. 4
1989		Ibogaine added to the list of "doping substances" banned by the International Olympic Committee. 2
Dec 12, 2001		The London Ibogaine Conference [Details] [More Info] Held in London, England, and produced by The London Voluntary Sector Resource Centre, this conference presented discussions about the sacramental use of iboga by indigenous peoples in west Africa, and its use for the treatment of drug dependence in the West. Presentations were given by Dana Beal, Patrick Kroupa, Mallendi, Brian Mariano, John Pablo, and Nick Sandberg. Tickets were 40 pounds.

References

Ott J. Pharmacotheon, The Natural Products Co. 1993.
Goutarel R, Gollnhofer O, Sillans R. "Pharmacodynamics And Therapeutic Applications Of Iboga and Ibogaine". Psychedelic Monographs and Essays #6. Ed. Thomas Little. PM & E Publishing Group, 1993. 70-111.
Anonymous. Ibogaine FAQ. Apr 1995.
Ravalec V, Mallendi, Paicheler A. Iboga: The Visionary Root of African Shamanism. Park Street Press. 2007.
Bureau of Drug Abuse Control. Micro-Gram. Dec 1967;1(2):1.
"Ibogaine". PharmChem Newsletter. 1972;1(2).
Lotsof H. U.S. Patent 4,499,096.